Dew. Believe AMRN is halted FDA appeared to inadvertently leak their position re new label , in response to a citizen petition asking them to require Amarin to run tests on the placebo used . The FDA denied the petition and laid out the reasons why ....mineral oil placebo had little affect on trial results and benefit was seen across multiple sub groups Kiwi